The Business Research Company's Farber's Disease Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% on all global market reports with code ONLINE30 - stay informed ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

PORTLAND, OR, UNITED STATES, July 3, 2025 /EINPresswire.com/ -- (Global value: USD 5.4 billion (2021) → USD 7.9 billion (2031) | CAGR 3.8 %) The growth of paresthesia treatment market share is driven ...

Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’ By Meg Tirrell, CNN May 30, 2025 Updated Jun 2, 2025 ...

And while Pfizer is making big bets on cancer research, its CEO said he’s not taking his foot off the pedal with investment in vaccines either, despite a “very big gap” between the company ...

Pfizer’s drug, Braftovi, was shown to double the length of time patients with an aggressive form of colorectal cancer lived with treatment: an average of 30 months compared with 15 in a clinical ...

CEO Dr. Albert Bourla says Pfizer has some "very real concerns" about new requirements for clinical trials of Covid-19 vaccines. - Patrick T. Fallon/AFP/Getty Images ...

And while Pfizer is making big bets on cancer research, its CEO said he’s not taking his foot off the pedal with investment in vaccines either, despite a “very big gap” between the company and HHS – ...